Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Genecon Biotechnologies appears to be the English name used for Jiangsu Genecon Biotechnologies Co., Ltd., a China-based company headquartered in Nantong, Jiangsu. Public business-registration information indicates the company develops skin bioengineering technologies and manufactures and sells skincare products. Patent records link the company to small interfering RNA technology targeting microphthalmia-associated transcription factor for inhibiting melanin production, suggesting a focus on pigmentation-related cosmetic and potentially dermatologic applications. Available evidence points to a niche health/beauty biotechnology business rather than a traditional therapeutics developer with a disclosed clinical pipeline. The company appears to be active and privately held.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Genecon Biotechnologies.